Kuopio University Hospital is a teaching hospital of the University of Eastern Finland along Puijonlaaksontie at the Puijonlaakso district in Kuopio, Finland.

During the past decade, Kuopion yliopistollinen sairaala conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kuopion yliopistollinen sairaala" #1 sponsor was "Bayer" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "AM-Pharma" with 1 trials sponsored, "Inotrem" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kuopion yliopistollinen sairaala" #1 collaborator was "PPD" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kuopion yliopistollinen sairaala" are "Acute Kidney Injury" (1 trials), "Acute Respiratory Distress Syndrome" (1 trials), "Anti- VGF Inhibitor" (1 trials), "Atrial Fibrillation" (1 trials) and "Basal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Kuopion yliopistollinen sairaala" in a lesser frequency.

Most popular intervention types in "Kuopion yliopistollinen sairaala" are "Drug" (7 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "BAY1097761 Active Dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kuopion yliopistollinen sairaala" are 7 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kuopion yliopistollinen sairaala". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Kuopion yliopistollinen sairaala, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kuopion yliopistollinen sairaala, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".